Data from previous studies9, 10 have demonstrated that cardiac hepatocyte growth factor (HGF) is a potent angiogenic, anti-apoptotic, and anti-fibrotic agent for treating myocardial infarction (MI). The gene discussed is HGF; the disease is myocardial infarction.